Abstract Background: Toxoplasma gondii infection causes adverse pregnancy outcomes by affecting the expression of immunotolerant molecules in decidual immune cells. Galectin-9 (Gal-9) is widely expressed in decidual macrophages (dMφ) and is crucial for maintaining normal pregnancy by interacting with the immunomodulatory protein Tim-3. However, the effects of T. gondii infection on Gal-9 expression levels in dMφ during pregnancy, as well as the impact of altered Gal-9 expression levels on the maternal-fetal tolerance function of dNK cells, are still unknown. Methods: Pregnancy outcomes of T. gondii infected C57BL/6 and Lgals9-/- pregnant mice models were recorded. The pathological change was evaluated by HE staining. The expression of Gal-9 in T. gondii infected dMφ were examined using flow cytometry and immunofluorescence. Expressions of Gal-9, JNK, p-JNK, FOXO1 were detected by Western Blot. The binding of FOXO1 to the promoter of Lgals9 was determined by ChIP-PCR. Supernatants from control or infected dMφ was co-cultured with purified human dNK cells with or without recombinant human Gal-9 protein (rhGal-9) or neutralized antibody of Tim-3, the expression of ERK, p-ERK, CREB, p-CREB, T-bet, IL-10 and IFN-γ were assayed by Western Blot. Results: T. gondii infection promoted JNK phosphorylation and increased FOXO1 expression in dMφ, resulting in reduction of Gal-9 due to the elevated binding of FOXO1 with Lgals9 promoter. Downregulation of Gal-9 enhanced the phosphorylation of ERK and inhibited phosphorylation of CREB and expression of IL-10, and promoted the expression of T-bet and IFN-γ. In mice model, knockout of Gal-9 aggravated adverse pregnancy outcomes caused by T. gondii infection during pregnancy. Conclusions: T. gondii infection suppressed Gal-9 expression in dMφ by activating the JNK/FOXO1 signaling pathway, and reduction of Gal-9 resulted in dysfunction of dNK via Gal-9/Tim-3 interaction. This study provided new insights for the molecular mechanisms of the adverse pregnancy outcomes caused by T. gondii.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: